Skip to main content


Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 12/2008

Ausgabe 12/2008

Inhaltsverzeichnis ( 15 Artikel )

01.12.2008 | Original Article | Ausgabe 12/2008

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration

Gregory Driessens, Laurence Gordower, Lise Nuttin, Patrick Stordeur, Didier Blocklet, Dominique Egrise, Thierry Velu, Catherine Bruyns

01.12.2008 | Original Article | Ausgabe 12/2008

Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors

Tania Benatar, Ming Y. Cao, Yoon Lee, Hui Li, Ningping Feng, Xiaoping Gu, Vivian Lee, Hongnan Jin, Ming Wang, Sandy Der, Jeff Lightfoot, Jim A. Wright, Aiping H. Young

01.12.2008 | Original Article | Ausgabe 12/2008

Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8+ T cells-mediated protection against melanoma B16 challenge

Zaima Mazorra, Circe Mesa, Audry Fernández, Luis E. Fernández

01.12.2008 | Original Article | Ausgabe 12/2008

Targeting activity of a TCR/IL-2 fusion protein against established tumors

Jinghai Wen, Xiaoyun Zhu, Bai Liu, Lijing You, Lin Kong, Hyung-il Lee, Kai-ping Han, Jeffrey L. Wong, Peter R. Rhode, Hing C. Wong

01.12.2008 | Original Article | Ausgabe 12/2008

Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood

Camilla Jandus, Gilles Bioley, Daniel E. Speiser, Pedro Romero

01.12.2008 | Original Article | Ausgabe 12/2008

Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo

Abdeljabar El Andaloussi, Yu Han, Maciej S. Lesniak

01.12.2008 | Original Article | Ausgabe 12/2008

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Asna Amin, Linda C. Benavides, Jarrod P. Holmes, Jeremy D. Gates, Mark G. Carmichael, Matthew T. Hueman, Elizabeth A. Mittendorf, Catherine E. Storrer, Yusuf H. Jama, Dianna Craig, Alex Stojadinovic, Sathibalan Ponniah, George E. Peoples

01.12.2008 | Original Article | Ausgabe 12/2008

Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma

Michael J. Ciesielski, Danuta Kozbor, Carla A. Castanaro, Tara A. Barone, Robert A. Fenstermaker

01.12.2008 | Original Article | Ausgabe 12/2008 Open Access

Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus

Marinke Westerterp, Marja A. Boermeester, Jikke M. T. Omloo, Maarten C. C. M. Hulshof, Walter L. Vervenne, Rene Lutter, Theo A. Out, J. Jan B. van Lanschot

01.12.2008 | Original Article | Ausgabe 12/2008

Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation

Dan Zhu, Laura G. Corral, Yuedi W. Fleming, Bernd Stein

01.12.2008 | Original Article | Ausgabe 12/2008

Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity

Shinjiro Yamaguchi, Tomohide Tatsumi, Tetsuo Takehara, Akira Sasakawa, Hayato Hikita, Keisuke Kohga, Akio Uemura, Ryotaro Sakamori, Kazuyoshi Ohkawa, Norio Hayashi

01.12.2008 | Original Article | Ausgabe 12/2008 Open Access

RhoC a new target for therapeutic vaccination against metastatic cancer

Lynn Wenandy, Rikke Bæk Sørensen, Inge Marie Svane, Per thor Straten, Mads Hald Andersen

01.12.2008 | Original Article | Ausgabe 12/2008

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability

Michael M. Schmidt, Greg M. Thurber, K. Dane Wittrup

01.12.2008 | Original Article | Ausgabe 12/2008

Intratumoral immunocytokine treatment results in enhanced antitumor effects

Erik E. Johnson, Hillary D. Lum, Alexander L. Rakhmilevich, Brian E. Schmidt, Meghan Furlong, Ilia N. Buhtoiarov, Jacquelyn A. Hank, Andrew Raubitschek, David Colcher, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel

01.12.2008 | Short Communication | Ausgabe 12/2008

HLA typing demands for peptide-based anti-cancer vaccine

Dirk Nagorsen, Eckhard Thiel

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.